版本:
中国

BRIEF-TherapeuticsMD provides additional information on TX-004HR regulatory update

April 19 TherapeuticsMD Inc:

* TherapeuticsMD provides additional information on TX-004HR regulatory update

* TherapeuticsMD - expects FDA will finalize an action on NDA for TX-004HR on or before originally scheduled PDUFA target action date of May 7, 2017

* At this time, company is not aware of nature of deficiencies in NDA identified by FDA Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐